Search Results - "Metivier, S"

Efficacy and Safety of Sofosbuvir‐Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation by Kamar, N., Marion, O., Rostaing, L., Cointault, O., Ribes, D., Lavayssière, L., Esposito, L., Del Bello, A., Métivier, S., Barange, K., Izopet, J., Alric, L.

“…There is no approved therapy for hepatitis C virus (HCV) infection after kidney transplantation, and no data regarding the use of new‐generation direct…”
Get full text

Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease by BUREAU, C., METIVIER, S., PERON, J. M., SELVES, J., ROBIC, M. A., GOURRAUD, P. A., ROUQUET, O., DUPUIS, E., ALRIC, L., VINEL, J. P.

“…Summary Background  Hepatic venous pressure gradient (HVPG) is a prognostic marker in patients with cirrhosis. Transient elastography measures liver stiffness…”
Get full text

Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme by Leroy, V, Hézode, C, Métivier, S, Tateo, M, Conti, F, Nguyen-Khac, E, Lacoste, D, Vergniol, J, Truchi, R, Guyader, D, Riachi, G, Michau, C, Blaison, D, Oberti, F, Fontaine, H, Di Martino, V, Bronowicki, J.-P, Akremi, R, Bennai, Y, Filipovics, A, Pageaux, G.-P

Get full text

Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH) by Carrieri, Maria Patrizia, Serfaty, Lawrence, Vilotitch, Antoine, Winnock, Maria, Poizot-Martin, Isabelle, Loko, Marc-Arthur, Lions, Caroline, Lascoux-Combe, Caroline, Roux, Perrine, Salmon-Ceron, Dominique, Spire, Bruno, Dabis, Francois

“…Background. Diabetes and insulin resistance (IR) is common in human immunodeficiency virus–hepatitis C virus (HIV–HCV)-coinfected patients, a population also…”
Get full text

Retreatment with Direct Active Antivirals of genotype 1, 3 and 4 chronic hepatitis C patients who previously failed an anti-NS5A-containing regimen in real world by Halfon, P, Scholtes, C, Izopet, J, Larrat, S, Penaranda, G, Trimoulet, P, Zoulim, F, Alric, L, Metivier, S, Bourliere, M, Leroy, V, Ouzan, D, de Ledinghen, V, Mohamed, S, Thelu, M.-A, Abravanel, F

Get full text

O056 : Ledipasvir/sofosbuvir treatment results in high SVR rates in patients with chronic genotype 4 and 5 HCV infection by Abergel, A, Loustaud-Ratti, V, Metivier, S, Jiang, D, Kersey, K, Knox, S.J, Pang, P.S, Samuel, D, Asselah, T

Get full text

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data) by Barré, Tangui, Mercié, Patrick, Lions, Caroline, Miailhes, Patrick, Zucman, David, Aumaître, Hugues, Esterle, Laure, Sogni, Philippe, Carrieri, Patrizia, Salmon-Céron, Dominique, Marcellin, Fabienne

“…Thanks to direct-acting antivirals, hepatitis C virus (HCV) infection can be cured, with similar rates in HCV-infected and HIV-HCV co-infected patients. HCV…”
Get full text

Funding of direct acting antivirals for hepatitis C in psychiatry setting by Eyvrard, F, Metivier, S, Sorli, S C, Cabrit, L, Jullien, A, Cestac, P

Get more information

LP23 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HIV–HCV co-infection: interim analysis of a French multicenter compassionate use program by Fontaine, H, Lacombe, K, Dhiver, C, Rosenthal, E, Metivier, S, Antonini-Michelle, T, Valantin, M.A, Cotte, L, Botero, J, Harent, S, Batisse, D, Pageaux, G.-P, Aumaitre, H, Dominguez, S, De Ledinghen, V, Leroy, V, Dabis, F, Wittkop, L, Filipovics, A, Barlet, M.H, Bennai, Y, Salmon, D

Get full text

Ledipasvir/Sofosbuvir in NS3/4A Protease Inhibitor-Experienced Subjects with HCV Genotype 1 and HIV-Co-Infection Final Results of the ANRS HC31 Softrih Study by Rosenthal, E, Fougerou-Leurent, C, Renault, A, Teicher, E, Dominguez, S, Naqvi, A, Metivier, S, Cotte, L, Reynes, J, Valantin, M.-A, Leroy, V, Pageaux, G.-P, Pol, S, Piroth, L, Perre, P, Morlat, P, Salmon-Ceron, D, Chas, J, Jeantils, V, de Truchis, P, Allègre, T, Dupon, M, Raffi, F, Yazdanpanah, Y, Poizot-Martin, I, Neau, D, Girard, P.-M, Zucman, D, Garraffo, R, Chevaliez, S, Carrieri, P, Aumaitre, H, Lacombe, K, Bailly, F, Billaud, E, Pailhé, A, Amri, I, Bourlière, M, Bellissant, E, Molina, J.-M

Get full text

LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather by Fontaine, H, Hezode, C, Zoulim, F, Samuel, D, Bourliere, M, Haour, G, Dorival-Mouly, C, Leroy, V, De Ledinghen, V, Lucier, S, Larrey, D, Tran, A, Metivier, S, Benhamou, Y, Hubert-Fouchard, I, Habersetzer, F, Marcellin, P, Mathurin, P, Alric, L, Bronowicki, J.-P, Guyader, D, Loustaud-Ratti, V, Minello, A, Riachi, G, Rosa, I, Simony, M, Diallo, A, Carrat, F, Pol, S

Get full text

O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTS by Manns, M, Pol, S, Jacobson, I, Marcellin, P, Gordon, S, Peng, C.-Y, Chang, T.-T, Everson, G, Heo, J, Gerken, G, Yoffe, B, Towner, W.J, Bourliere, M, Metivier, S, Chu, C.-J, Sievert, W, Bronowicki, J.-P, Thabut, D, Lee, Y.-J, Kao, J.-H, McPhee, F, Kopit, J, Mendez, P, Linaberry, M, Hughes, E, Noviello, S

Get full text

P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic by Bronowicki, J.-P, Fontaine, H, Dufour, C, Zoulim, F, Larrey, D, Canva, V, Samuel, D, Poynard, T, Marcellin, P, De Ledinghen, V, Bourlière, M, Alric, L, Zarski, J.-P, Raabe, J.-J, Serfaty, L, Metivier, S, Riachi, G, Abergel, A, Loustaud-Ratti, V, Causse, X, Guyader, D, Bernard, P.-H, Attali, P, Di Martino, V, Cacoub, P, Cales, P, Tran, A, Rosa, I, Grando-Lemaire, V, Portal, I, Dao, T, Lucidarme, D, Fontanges, T, Barthe, Y, Pawlotsky, J.-M, Pol, S, Carrat, F, Hezode, C

Get full text

Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy by Nicot, F, Alric, L, Barange, K, Métivier, S, Dramard, J.M, Combis, J.M, Castan, B, Meurisse, J.J, Payen, J.L, Garipuy, D, Desmorat, H, Peron, J.M, Thebault, S, Morin, T, Renou, C, Barel, P, Guerin, B, Imbert, Y, Sire, S, Sauné, K, Chatelut, E, Izopet, J

“…New factors that influence the viral response in HCV non-genotype 2/3 patients must be identified in order to optimize anti-HCV treatment. This multicenter…”
Get full text

1156 USE OF EPOETIN BETA IN HEPATITIS C PATIENTS: SAFETY DATA FROM THE FRENCH TRIAL NEOS - INTERIM ANALYSIS AT SIX MONTHS by Roudot-Thoraval, F, Bourlière, M, Tran, A, Habersetzer, F, Larrey, D, Di Martino, V, Guyader, D, Metivier, S, Rouanet, S, Cartier, V, Bronowicki, J.-P

Get full text

Gene expression profiling demonstrates differential expression of osteopontin in follicular thyroid carcinomas compared to normal thyroid tissue in dogs by Metivier, K. S, Deitz, K, Xu, W. W, Conzemius, M, Wilke, V. L

“…Follicular thyroid carcinoma (FTC) is an aggressive tumour in dogs with little known about its molecular pathogenesis. The overall goal of this study was to…”
Get full text

In vitro rooting of microshoots of Cotinus coggygria Mill, a woody ornamental plant by Metivier, Peter S. R., Yeung, Edward C., Patel, Kamlesh R., Thorpe, Trevor A.

“…Studies on rooting of microshoots of smokebush (Cotinus coggygria Mill, var. Royal Purple), a woody ornamental, were carried out in vitro. Microshoots were…”
Get full text

[77] PROSPECTIVE ASSESSMENT OF LIVER STIFFNESS FOR THE NON-INVASIVE PREDICTION OF PORTAL HYPERTENSION by Bureau, C, Metivier, S, Peron, T.M, Robic, M.A, Rouquet, O, Dupuis, E, Vinel, T.P

Get full text

Pilot study of interferon-α-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1 by Alric, L., Thebault, S., Peron, J.-M., Balard, P., Metivier, S., Pipy, B., Izopet, J., Vinel, J.-P.

“…The aim of this randomized prospective study was to assess the efficacy and safety of a triple therapy with interferon‐α (IFN‐α)‐ribavirin‐interleukin‐2 (IL‐2)…”
Get full text

230 COMPARISON OF SIX SERUM TESTS, LIVER STIFFNESS AND HVPG IN THE PREDICTION OF CLINICAL DECOMPENSATION IN CHRONIC LIVER DISEASES by Procopet, B, Robic, M.A, Grigorescu, M, Métivier, S, Tantau, M, Peron, J.M, Vinel, J.P, Bureau, C

Get full text